🚀 Available now on the Latent Labs Platform with free tier access:

* No-code interface
* Upload targets, select epitopes, generate binders
* 10x faster than previous methods
* Computational ranking for lab prioritization

⚡ Watch Latent-X generate a picomolar mini-binders from scratch — solving the geometric puzzle of binding at the all-atom level in real-time.

Every atom placed with precision to create the biochemistry required for tight, specific binding.

🧬Latent-X is our first frontier model for protein design.

For mini-binders, our AI model achieved picomolar binding affinities — the strongest reported vs prior methods in head-to-head lab validation.

Explore our best binders here: platform.latentlabs.com

More details on the breakthrough in this🧵

5 months from funding to shipping our first frontier model. Latent-X achieves state-of-the-art hit rates for macrocycles and mini-binders, with picomolar binding affinities — a breakthrough in de novo protein binder design.

Available now on our no-code platform!

Catch @saakohl.bsky.social's panel with Glen Gowers, Michael Curtis, Amber Salzman, and Oliver Barnes at the @financialtimes.com Biotech Summit this Thursday discussing what the future holds for AI-driven drug discovery.

Latent Labs is partnering with @awscloud.bsky.social to super‑charge generative AI for the life sciences. Together, we’ll scale access to protein design tools that help scientists discover breakthrough therapies faster.